Skip to main content
. 2020 Oct 13;12(10):2946. doi: 10.3390/cancers12102946

Figure 1.

Figure 1

Melanoma and basal cell carcinoma (BCC) have similar responses to immunotherapy. (A,B) Dimensionality reduction of melanoma (A) and BCC (B). (C,D) Distribution of cells from responders and non-responders, grouped by cluster. (EH) Percentage of macrophages (E), memory B cells (F), CD8+ T cells (G) and T regulatory cells (Tregs) (H) per patient, grouped by responders and non-responders.